Provided by Tiger Trade Technology Pte. Ltd.

Zoetis

115.67
-0.3200-0.28%
Post-market: 116.000.3300+0.29%19:43 EDT
Volume:11.42M
Turnover:1.32B
Market Cap:48.83B
PE:19.21
High:117.19
Open:115.95
Low:114.36
Close:115.99
52wk High:172.23
52wk Low:114.36
Shares:422.13M
Float Shares:422.00M
Volume Ratio:2.59
T/O Rate:2.71%
Dividend:2.03
Dividend Rate:1.75%
EPS(TTM):6.02
EPS(LYR):6.02
ROE:65.99%
ROA:15.25%
PB:14.66
PE(LYR):19.21

Loading ...

Zoetis Shares Slide 13.8% After Co Cuts FY Revenue Outlook

THOMSON REUTERS
·
Nov 04, 2025

This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps. -- Barrons.com

Dow Jones
·
Nov 04, 2025

BUZZ-Zoetis falls after cutting annual revenue forecast

Reuters
·
Nov 04, 2025

GUIDANCE: (ZTS) Zoetis Expects Full Year 2025 Revenue Range $9.40B - $9.48B, vs. FactSet Est of $9.51B

MT Newswires Live
·
Nov 04, 2025

GUIDANCE: (ZTS) Zoetis Expects Full-Year 2025 Adjusted EPS Range $6.30 - $6.40, vs. FactSet Est of $6.35

MT Newswires Live
·
Nov 04, 2025

Zoetis Shares Fall 7.1% Premarket After Co Cuts FY Revenue Outlook

THOMSON REUTERS
·
Nov 04, 2025

Zoetis edges past Q3 revenue estimates, revises FY sales view

Reuters
·
Nov 04, 2025

Stock Track | Zoetis Plunges 5.09% Pre-Market on Q3 Revenue Miss Despite Earnings Beat

Stock Track
·
Nov 04, 2025

Stock Track | Zoetis Shares Plunge 5.09% Pre-Market on Q3 Revenue Miss Despite Earnings Beat

Stock Track
·
Nov 04, 2025

Zoetis reports $9.3 billion revenue for 2024

Reuters
·
Nov 04, 2025

Zoetis Q3 Adj. EPS $1.70 Beats $1.62 Estimate, Sales $2.400B Miss $2.411B Estimate

Benzinga
·
Nov 04, 2025

BRIEF-Zoetis Q3 Revenue USD 2,400 Million Vs. IBES Estimate USD 2,421 Million

Reuters
·
Nov 04, 2025

Zoetis Inc - Q3 Adj Diluted EPS $1.70

THOMSON REUTERS
·
Nov 04, 2025

Zoetis Inc - FY Outlook Adj Diluted EPS Between $6.30 to $6.40

THOMSON REUTERS
·
Nov 04, 2025

Zoetis Q3 EPS USD 1.63

THOMSON REUTERS
·
Nov 04, 2025

Zoetis Names Kevin Esch as New R&D President After Rob Polzer Retirement

Reuters
·
Nov 04, 2025

Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026

THOMSON REUTERS
·
Nov 04, 2025

Zoetis Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 30, 2025

Zoetis Receives European Commission Marketing Authorization For Portela® (Relfovetmab) To Alleviate Pain Associated With Osteoarthritis In Cats

Reuters
·
Oct 29, 2025

Zoetis Wins EU Approval for Portela to Treat Osteoarthritis Pain in Cats

Reuters
·
Oct 29, 2025